Skip to main content
Earnings Labs
Nektar Therapeutics logo

Nektar Therapeutics (NKTR)

NASDAQ·Healthcare·Biotechnology

$38.00

+1.46%

Mkt Cap $1.07B

Analyst Ratings

Buy

7

Hold

2

Sell

0

Price Target (19 analysts)

$146.00

Range $50.00 – $192.00

Implied Upside

+284.2%

Consensus $146.00 vs current $38.00